6/25/2025 Categories: Industries Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise
9/3/2019 Angelini Pharma launches lurasidone hydrocloride-based Latuda in Spain for the treatment of shizophrenia
8/29/2019 Angelini Pharma announces the acquisition of two OTC products from Sanofi in Germany and Austria
Angelini Industries
